Earnings ·
Bioceres Crop Solutions Corp. reported fiscal fourth quarter and full-year 2026 results, with Q4 revenues of $55.9…
BIOXBioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. reported fiscal fourth quarter and full-year 2026 results, with Q4 revenues of $55.9 million and full-year revenues declining 18% to $238.3 million due to the reconfiguration of its Seeds business. The company returned to positive Adjusted EBITDA in Q4 at $0.6 million, driven by a 19% reduction in SG&A expenses, though it reported a net loss from continuing operations of $31.8 million for the quarter and $54.4 million for the year. Concurrently, Nasdaq approved Bioceres' transfer to The Nasdaq Capital Market effective September 18, 2026, granting an additional 180-day compliance period until March 15, 2027, to regain the minimum $1.00 bid price requirement or implement a reverse stock split. Bioceres Crop Solutions Corp. operates in the agricultural technology industry, developing and commercializing productivity solutions such as microbial ag-inputs and crop nutrition products.